These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 22788994)
61. Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX. Alterio V; Hilvo M; Di Fiore A; Supuran CT; Pan P; Parkkila S; Scaloni A; Pastorek J; Pastorekova S; Pedone C; Scozzafava A; Monti SM; De Simone G Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16233-8. PubMed ID: 19805286 [TBL] [Abstract][Full Text] [Related]
62. Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors. Di Fiore A; Maresca A; Supuran CT; De Simone G Chem Commun (Camb); 2012 Sep; 48(70):8838-40. PubMed ID: 22836518 [TBL] [Abstract][Full Text] [Related]
63. Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today? Mishra CB; Tiwari M; Supuran CT Med Res Rev; 2020 Nov; 40(6):2485-2565. PubMed ID: 32691504 [TBL] [Abstract][Full Text] [Related]
64. Designing of Novel Carbonic Anhydrase Inhibitors and Activators. Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):51-70. PubMed ID: 15320807 [TBL] [Abstract][Full Text] [Related]
65. Natural product coumarins that inhibit human carbonic anhydrases. Davis RA; Vullo D; Maresca A; Supuran CT; Poulsen SA Bioorg Med Chem; 2013 Mar; 21(6):1539-43. PubMed ID: 22892213 [TBL] [Abstract][Full Text] [Related]
66. Carbonic anhydrase inhibitors. Supuran CT; Scozzafava A; Casini A Med Res Rev; 2003 Mar; 23(2):146-89. PubMed ID: 12500287 [TBL] [Abstract][Full Text] [Related]
67. Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019. Supuran CT; Altamimi ASA; Carta F Expert Opin Ther Pat; 2019 Oct; 29(10):781-792. PubMed ID: 31596641 [No Abstract] [Full Text] [Related]
68. Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery. Nocentini A; Supuran CT Expert Opin Drug Discov; 2019 Nov; 14(11):1175-1197. PubMed ID: 31436118 [No Abstract] [Full Text] [Related]
69. The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors. Temperini C; Innocenti A; Scozzafava A; Parkkila S; Supuran CT J Med Chem; 2010 Jan; 53(2):850-4. PubMed ID: 20028100 [TBL] [Abstract][Full Text] [Related]
70. An overview of carbohydrate-based carbonic anhydrase inhibitors. Cuffaro D; Nuti E; Rossello A J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1906-1922. PubMed ID: 33078634 [TBL] [Abstract][Full Text] [Related]
71. Design and synthesis of thiourea compounds that inhibit transmembrane anchored carbonic anhydrases. Moeker J; Teruya K; Rossit S; Wilkinson BL; Lopez M; Bornaghi LF; Innocenti A; Supuran CT; Poulsen SA Bioorg Med Chem; 2012 Apr; 20(7):2392-404. PubMed ID: 22370338 [TBL] [Abstract][Full Text] [Related]
72. Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides. Nishimori I; Vullo D; Innocenti A; Scozzafava A; Mastrolorenzo A; Supuran CT Bioorg Med Chem Lett; 2005 Sep; 15(17):3828-33. PubMed ID: 16039848 [TBL] [Abstract][Full Text] [Related]
74. Quantitative Characterization of the Interaction Space of the Mammalian Carbonic Anhydrase Isoforms I, II, VII, IX, XII, and XIV and their Inhibitors, Using the Proteochemometric Approach. Rasti B; Karimi-Jafari MH; Ghasemi JB Chem Biol Drug Des; 2016 Sep; 88(3):341-53. PubMed ID: 26990115 [TBL] [Abstract][Full Text] [Related]
75. New zinc binding motifs in the design of selective carbonic anhydrase inhibitors. Winum JY; Scozzafava A; Montero JL; Supuran CT Mini Rev Med Chem; 2006 Aug; 6(8):921-36. PubMed ID: 16918498 [TBL] [Abstract][Full Text] [Related]
76. Carbonic anhydrase inhibitor coated gold nanoparticles selectively inhibit the tumor-associated isoform IX over the cytosolic isozymes I and II. Stiti M; Cecchi A; Rami M; Abdaoui M; Barragan-Montero V; Scozzafava A; Guari Y; Winum JY; Supuran CT J Am Chem Soc; 2008 Dec; 130(48):16130-1. PubMed ID: 18989963 [TBL] [Abstract][Full Text] [Related]
80. Carbonic anhydrase inhibition/activation: trip of a scientist around the world in the search of novel chemotypes and drug targets. Supuran CT Curr Pharm Des; 2010; 16(29):3233-45. PubMed ID: 20819070 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]